Zhitong Finance App News, Tianchen Bio-B (01779.HK) issued an announcement. LP-003's clinical trial application for peanut allergy indications has been approved by the US Food and Drug Administration (FDA).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.